title: Contraceptive update Y2K: need for contraception and new contraceptive options.
abstract: Despite the major strides made in birth control, which have produced a decline in unintended pregnancies over the past decade and the lowest rates of teen pregnancies seen since 1974 (1,2), significant problems still remain. Almost half (48%) of US pregnancies in 1995 were unintended (1) and many more that were "intended" were not planned or prepared for (3). To optimize maternal and fetal outcomes, it is incumbent that physicians both emphasize the need for women to be physically, emotionally, and socially prepared for pregnancy before they conceive as well as ensure the availability of effective methods to allow them to do so. Today, contraceptives are available that permit couples to choose if and when to have children. Although only 5% of women who are sexually active and say they do not want to become pregnant are using no method of birth control (4), that group accounts for nearly 40% of the unintended pregnancies. More than half of all unintended pregnancies occur in women who had used a method in the month of conception (1). The strategy with these women should be to find ways to make the method they select work better for them or to switch them to more effective methods. Unfortunately, the most effective reversible methods are among the least utilized--in part because they have the highest initial costs. Some states, such as California and Maryland, have passed Contraceptive Equity Acts, which require insurance companies that provide any prescriptive drug coverage to cover all forms of prescription contraception. Many other states, as well as the federal government, are now considering similar legislation. It is important, therefore, both from the perspective of quality patient care and also from a fiscal standpoint, that all who care for reproductive-aged women become familiar with the full array of contraceptive options. This article will review the methods of reversible birth control now available in the United States, including the most recent efficacy rates and new practical tips to achieve better utilization, as well as summarize the features of some of the new options that may be nearing introduction.
authors.affiliation: Department of Obstetrics and Gynecology, UCLA School of Medicine, USA.
authors.forename: A
authors.initials: A
authors.lastname: Nelson
mesh_terms: D000293:Adolescent; D000328:Adult; D017280:Condoms; D003267:Contraception; D003274:Contraceptive Devices, Female; D003276:Contraceptives, Oral; D005260:Female; D006801:Humans; D016912:Levonorgestrel; D008297:Male; D017258:Medroxyprogesterone Acetate
chemical_list: D003276:Contraceptives, Oral; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate